Nausicalm
View our Nausicalm® product for the treatment of nausea and prevention of travel sickness.
Join our team
We’re always looking for talented people, please have a look at the careers we currently have available.
Latest news
Keep up to date with the latest news from AFT Pharmaceuticals
November 20, 2025
AFT delivers 10th consecutive first half revenue increase
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…
September 25, 2025
On track for $300m FY27 revenue; positive iron IV study result
– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …
May 26, 2025
AFT and Hikma extend US Maxigesic Cooperation
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….